Related Experiment Video

Updated: Jun 2, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

CHK1 inhibitors in combination chemotherapy: thinking beyond the cell cycle

Paul Dent1, Yong Tang, Adly Yacoub

  • 1Department of Neurosurgery, Virginia Commonwealth University, Massey Cancer Center, 401 College Street, Richmond, VA 23298-0035, USA. pdent@vcu.edu

Molecular Interventions
|May 5, 2011
PubMed

Insights

Checkpoint kinase 1 (Chk1) inhibitors show promise for cancer therapy by sensitizing cells to DNA-damaging drugs. However, compensatory pathway activation limits their clinical efficacy, necessitating further research into combined signaling contexts.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Pharmacology

Background:

  • Cellular DNA damage response involves cell cycle arrest mediated by numerous proteins.
  • Checkpoint kinases (Chks) are targets for inhibiting DNA damage signaling to enhance chemotherapy efficacy.
  • 7-Hydroxystaurosporine (UCN-01) inhibits Chk1 and has shown chemosensitizing effects.

Purpose of the Study:

  • To review the hypothesized actions of Chk1 inhibitors in cell cycle modulation.
  • To examine the impact of Chk1 inhibition on other cell survival signaling pathways.
  • To understand Chk1 inhibition in multiple signaling contexts for therapeutic development.

Main Methods:

  • Literature review of Chk1 inhibitors and their effects.
  • Analysis of signaling pathways affected by Chk1 inhibition.
  • Examination of clinical data and hypothesized mechanisms of action.

Main Results:

  • UCN-01 and other Chk1 inhibitors have faced challenges in clinical activity when combined with chemotherapy.
  • Inhibition of Chk1 may lead to compensatory activation of ATM and ERK1/2 pathways.
  • Inhibition of other enzyme activities might block Chk1 inhibitor-induced ERK1/2 activation and enhance toxicity.

Conclusions:

  • Understanding Chk1 inhibition's effects on compensatory pathways is crucial for improving therapeutic strategies.
  • Further research into combined signaling contexts is essential for the successful development of Chk1 inhibitors.
  • Targeting Chk1 requires a comprehensive understanding of its role in various cellular signaling networks.

More Related Videos

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols12:02

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols

Published on: June 6, 2017

Preparation of Primary Acute Lymphoblastic Leukemia Cells in Different Cell Cycle Phases by Centrifugal Elutriation09:09

Preparation of Primary Acute Lymphoblastic Leukemia Cells in Different Cell Cycle Phases by Centrifugal Elutriation

Published on: November 10, 2017

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...